Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Interleukin-22 regulates interferon lambda expression in a mice model of pseudomonas aeruginosa pneumonia.

Broquet A, Besbes A, Martin J, Jacqueline C, Vourc'h M, Roquilly A, Caillon J, Josien R, Asehnoune K.

Mol Immunol. 2020 Feb;118:52-59. doi: 10.1016/j.molimm.2019.12.003. Epub 2019 Dec 16.

PMID:
31855807
2.

Obesity paradox in cancer: Is bigger really better?

Ujvari B, Jacqueline C, Misse D, Amar V, Fitzpatrick JC, Jennings G, Beckmann C, Rome S, Biro PA, Gatenby R, Brown J, Almeida L, Thomas F.

Evol Appl. 2019 Apr 24;12(6):1092-1095. doi: 10.1111/eva.12790. eCollection 2019 Jun.

3.

Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

Papp-Wallace KM, Bethel CR, Caillon J, Barnes MD, Potel G, Bajaksouzian S, Rutter JD, Reghal A, Shapiro S, Taracila MA, Jacobs MR, Bonomo RA, Jacqueline C.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00105-19. doi: 10.1128/AAC.00105-19. Print 2019 May.

4.

Immunotherapy With Antiprogrammed Cell Death 1 Antibody Improves Outcome in a Mouse Model of Spinal Cord Injury Followed by Staphylococcus aureus Pneumonia.

Ruggeri T, Jacqueline C, Ambrosi X, Broquet A, Desfrançois J, Roquilly A, Altare F, Asehnoune K.

Crit Care Med. 2019 Jan;47(1):e28-e35. doi: 10.1097/CCM.0000000000003466.

PMID:
30303841
5.

Is adaptive therapy natural?

Thomas F, Donnadieu E, Charriere GM, Jacqueline C, Tasiemski A, Pujol P, Renaud F, Roche B, Hamede R, Brown J, Gatenby R, Ujvari B.

PLoS Biol. 2018 Oct 2;16(10):e2007066. doi: 10.1371/journal.pbio.2007066. eCollection 2018 Oct.

6.

Personal history of infections and immunotherapy: Unexpected links and possible therapeutic opportunities.

Jacqueline C, Bonnefoy N, Charrière GM, Thomas F, Roche B.

Oncoimmunology. 2018 Jun 11;7(8):e1466019. doi: 10.1080/2162402X.2018.1466019. eCollection 2018. Review.

7.

Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections.

Boudjemaa R, Steenkeste K, Jacqueline C, Briandet R, Caillon J, Boutoille D, Le Mabecque V, Tattevin P, Fontaine-Aupart MP, Revest M.

J Antimicrob Chemother. 2018 Sep 1;73(9):2418-2421. doi: 10.1093/jac/dky205.

8.

The macroecology of cancer incidences in humans is associated with large-scale assemblages of endemic infections.

Jacqueline C, Abbate JL, Sorci G, Guégan JF, Thomas F, Roche B.

Infect Genet Evol. 2018 Jul;61:189-196. doi: 10.1016/j.meegid.2018.03.016. Epub 2018 Mar 23.

PMID:
29578085
9.

Exoenzyme T Plays a Pivotal Role in the IFN-γ Production after Pseudomonas Challenge in IL-12 Primed Natural Killer Cells.

Vourc'h M, Roquilly A, Broquet A, David G, Hulin P, Jacqueline C, Caillon J, Retiere C, Asehnoune K.

Front Immunol. 2017 Oct 10;8:1283. doi: 10.3389/fimmu.2017.01283. eCollection 2017.

10.

The importance of cancer cells for animal evolutionary ecology.

Thomas F, Jacqueline C, Tissot T, Henard M, Blanchet S, Loot G, Dawson E, Mery F, Renaud F, Montagne J, Beckmann C, Biro PA, Hamede R, Ujvari B.

Nat Ecol Evol. 2017 Nov;1(11):1592-1595. doi: 10.1038/s41559-017-0343-z. No abstract available.

PMID:
29066812
11.

Can intestinal microbiota be associated with non-intestinal cancers?

Jacqueline C, Brazier L, Faugère D, Renaud F, Thomas F, Roche B.

Sci Rep. 2017 Oct 5;7(1):12722. doi: 10.1038/s41598-017-11644-9.

12.

Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model.

Broquet A, Jacqueline C, Davieau M, Besbes A, Roquilly A, Martin J, Caillon J, Dumoutier L, Renauld JC, Heslan M, Josien R, Asehnoune K.

Sci Rep. 2017 Sep 8;7(1):11010. doi: 10.1038/s41598-017-11518-0.

13.

Immune discrepancies during in vitro granuloma formation in response to Cutibacterium (formerly Propionibacterium) acnes infection.

Aubin GG, Ada Da Silva G, Eishi Y, Jacqueline C, Altare F, Corvec S, Asehnoune K.

Anaerobe. 2017 Dec;48:172-176. doi: 10.1016/j.anaerobe.2017.08.014. Epub 2017 Aug 30.

PMID:
28859990
14.

Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections.

Roquilly A, McWilliam HEG, Jacqueline C, Tian Z, Cinotti R, Rimbert M, Wakim L, Caminschi I, Lahoud MH, Belz GT, Kallies A, Mintern JD, Asehnoune K, Villadangos JA.

Immunity. 2017 Jul 18;47(1):135-147.e5. doi: 10.1016/j.immuni.2017.06.021.

15.

In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agents.

Jacqueline C, Howland K, Chesnel L.

J Glob Antimicrob Resist. 2017 Sep;10:326-329. doi: 10.1016/j.jgar.2017.04.003. Epub 2017 Jul 6.

PMID:
28689923
16.

Infections and cancer: the "fifty shades of immunity" hypothesis.

Jacqueline C, Tasiemski A, Sorci G, Ujvari B, Maachi F, Missé D, Renaud F, Ewald P, Thomas F, Roche B.

BMC Cancer. 2017 Apr 12;17(1):257. doi: 10.1186/s12885-017-3234-4.

17.

Cancer: A disease at the crossroads of trade-offs.

Jacqueline C, Biro PA, Beckmann C, Moller AP, Renaud F, Sorci G, Tasiemski A, Ujvari B, Thomas F.

Evol Appl. 2016 Dec 26;10(3):215-225. doi: 10.1111/eva.12444. eCollection 2017 Mar.

18.

Interaction of Cutibacterium ( formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development.

Aubin GG, Baud'huin M, Lavigne JP, Brion R, Gouin F, Lepelletier D, Jacqueline C, Heymann D, Asehnoune K, Corvec S.

Sci Rep. 2017 Feb 20;7:42918. doi: 10.1038/srep42918.

19.

Cancer brings forward oviposition in the fly Drosophila melanogaster.

Arnal A, Jacqueline C, Ujvari B, Leger L, Moreno C, Faugere D, Tasiemski A, Boidin-Wichlacz C, Misse D, Renaud F, Montagne J, Casali A, Roche B, Mery F, Thomas F.

Ecol Evol. 2016 Dec 20;7(1):272-276. doi: 10.1002/ece3.2571. eCollection 2017 Jan.

20.

Interactions between immune challenges and cancer cells proliferation: timing does matter!

Jacqueline C, Bourfia Y, Hbid H, Sorci G, Thomas F, Roche B.

Evol Med Public Health. 2016 Oct 2;2016(1):299-311. Print 2016.

21.

New Insight into Daptomycin Bioavailability and Localization in Staphylococcus aureus Biofilms by Dynamic Fluorescence Imaging.

Boudjemaa R, Briandet R, Revest M, Jacqueline C, Caillon J, Fontaine-Aupart MP, Steenkeste K.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4983-90. doi: 10.1128/AAC.00735-16. Print 2016 Aug.

22.

Innate immune evasion of Escherichia coli clinical strains from orthopedic implant infections.

Crémet L, Broquet A, Jacqueline C, Chaillou C, Asehnoune K, Corvec S, Caroff N.

Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):993-9. doi: 10.1007/s10096-016-2628-6. Epub 2016 Apr 2.

PMID:
27039343
23.

MIC score, a new tool to compare bacterial susceptibility to antibiotics application to the comparison of susceptibility to different penems of clinical strains of Pseudomonas aeruginosa.

Bretonnière C, Maitte A, Caillon J, Potel G, Boutoille D, Jacqueline C, Guitton C.

J Antibiot (Tokyo). 2016 Nov;69(11):806-810. doi: 10.1038/ja.2016.38. Epub 2016 Mar 30.

PMID:
27025352
24.

Adaptive processes of Staphylococcus aureus isolates during the progression from acute to chronic bone and joint infections in patients.

Trouillet-Assant S, Lelièvre L, Martins-Simões P, Gonzaga L, Tasse J, Valour F, Rasigade JP, Vandenesch F, Muniz Guedes RL, Ribeiro de Vasconcelos AT, Caillon J, Lustig S, Ferry T, Jacqueline C, Loss de Morais G, Laurent F.

Cell Microbiol. 2016 Oct;18(10):1405-14. doi: 10.1111/cmi.12582. Epub 2016 Apr 1.

PMID:
26918656
25.

New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.

Revest M, Jacqueline C, Boudjemaa R, Caillon J, Le Mabecque V, Breteche A, Steenkeste K, Tattevin P, Potel G, Michelet C, Fontaine-Aupart MP, Boutoille D.

J Antimicrob Chemother. 2016 May;71(5):1291-9. doi: 10.1093/jac/dkv496. Epub 2016 Feb 6.

26.

Host manipulation by cancer cells: Expectations, facts, and therapeutic implications.

Tissot T, Arnal A, Jacqueline C, Poulin R, Lefèvre T, Mery F, Renaud F, Roche B, Massol F, Salzet M, Ewald P, Tasiemski A, Ujvari B, Thomas F.

Bioessays. 2016 Mar;38(3):276-85. doi: 10.1002/bies.201500163. Epub 2016 Feb 5. Review.

PMID:
26849295
27.

Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells.

Crémet L, Broquet A, Brulin B, Jacqueline C, Dauvergne S, Brion R, Asehnoune K, Corvec S, Heymann D, Caroff N.

Pathog Dis. 2015 Nov;73(8):ftv065. doi: 10.1093/femspd/ftv065. Epub 2015 Sep 1.

28.

IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis.

Martin JC, Bériou G, Heslan M, Bossard C, Jarry A, Abidi A, Hulin P, Ménoret S, Thinard R, Anegon I, Jacqueline C, Lardeux B, Halary F, Renauld JC, Bourreille A, Josien R.

Mucosal Immunol. 2016 Mar;9(2):539-49. doi: 10.1038/mi.2015.83. Epub 2015 Sep 2.

PMID:
26329427
29.

Evolutionary perspective of cancer: myth, metaphors, and reality.

Arnal A, Ujvari B, Crespi B, Gatenby RA, Tissot T, Vittecoq M, Ewald PW, Casali A, Ducasse H, Jacqueline C, Missé D, Renaud F, Roche B, Thomas F.

Evol Appl. 2015 Jul;8(6):541-4. doi: 10.1111/eva.12265. Epub 2015 May 27.

30.

Cancer: an emergent property of disturbed resource-rich environments? Ecology meets personalized medicine.

Ducasse H, Arnal A, Vittecoq M, Daoust SP, Ujvari B, Jacqueline C, Tissot T, Ewald P, Gatenby RA, King KC, Bonhomme F, Brodeur J, Renaud F, Solary E, Roche B, Thomas F.

Evol Appl. 2015 Jul;8(6):527-40. doi: 10.1111/eva.12232. Epub 2015 Mar 26. Review.

31.

Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants.

Sicard M, Launay E, Caillon J, Jacqueline C, Legrand A, Deslandes G, Navas D, Rozé JC, Guen CG.

Eur J Clin Pharmacol. 2015 May;71(5):611-5. doi: 10.1007/s00228-015-1813-3. Epub 2015 Mar 6.

PMID:
25740677
32.

Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage.

Roquilly A, Broquet A, Jacqueline C, Masson D, Segain JP, Braudeau C, Vourc'h M, Caillon J, Altare F, Josien R, Retière C, Villadangos J, Asehnoune K.

Crit Care Med. 2014 Dec;42(12):e752-61. doi: 10.1097/CCM.0000000000000658.

PMID:
25289930
33.

Impact of bacterial biofilm on the treatment of prosthetic joint infections.

Jacqueline C, Caillon J.

J Antimicrob Chemother. 2014 Sep;69 Suppl 1:i37-40. doi: 10.1093/jac/dku254. Review.

PMID:
25135088
34.

In vivo efficacy of ceftolozane against Pseudomonas aeruginosa in a rabbit experimental model of pneumonia: comparison with ceftazidime, piperacillin/tazobactam and imipenem.

Bretonnière C, Boutoille D, Caillon J, Desessard C, Guitton C, Potel G, Jacqueline C.

Int J Antimicrob Agents. 2014 Sep;44(3):218-21. doi: 10.1016/j.ijantimicag.2014.04.017. Epub 2014 Jun 6.

PMID:
25108877
35.

Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.

Broquet A, Roquilly A, Jacqueline C, Potel G, Caillon J, Asehnoune K.

Crit Care Med. 2014 Jun;42(6):e441-50. doi: 10.1097/CCM.0000000000000311.

PMID:
24732238
36.

Analysis of autofluorescence in polymorphonuclear neutrophils: a new tool for early infection diagnosis.

Monsel A, Lécart S, Roquilly A, Broquet A, Jacqueline C, Mirault T, Troude T, Fontaine-Aupart MP, Asehnoune K.

PLoS One. 2014 Mar 21;9(3):e92564. doi: 10.1371/journal.pone.0092564. eCollection 2014.

37.

Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.

Jacqueline C, Broquet A, Roquilly A, Davieau M, Caillon J, Altare F, Potel G, Asehnoune K.

J Infect Dis. 2014 Sep 1;210(5):814-23. doi: 10.1093/infdis/jiu145. Epub 2014 Mar 11.

PMID:
24620024
38.

Management of MRSA/GISA, VISA Endocarditis.

Jacqueline C, Caillon J, Boutoille D.

Curr Infect Dis Rep. 2013 Aug;15(4):329-34. doi: 10.1007/s11908-013-0349-x.

PMID:
23754455
39.

Toll-like receptor-4 agonist in post-haemorrhage pneumonia: role of dendritic and natural killer cells.

Roquilly A, Broquet A, Jacqueline C, Gautreau L, Segain JP, de Coppet P, Caillon J, Altare F, Josien R, Asehnoune K.

Eur Respir J. 2013 Nov;42(5):1365-78. doi: 10.1183/09031936.00152612. Epub 2013 Jan 11.

40.

Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response.

Jacqueline C, Roquilly A, Desessard C, Boutoille D, Broquet A, Le Mabecque V, Amador G, Potel G, Caillon J, Asehnoune K.

J Antimicrob Chemother. 2013 Jan;68(1):177-83. doi: 10.1093/jac/dks343. Epub 2012 Aug 30.

PMID:
22941899
41.

A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment.

Gaudin A, Jacqueline C, Gautier H, Desessard C, Le Mabecque V, Miegeville AF, Potel G, Bouler JM, Weiss P, Caillon J, Amador G.

Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):195-8. doi: 10.1007/s10096-012-1731-6. Epub 2012 Aug 25.

PMID:
22923229
42.

pH-controlled delivery of gentamicin sulfate from orthopedic devices preventing nosocomial infections.

Pichavant L, Amador G, Jacqueline C, Brouillaud B, Héroguez V, Durrieu MC.

J Control Release. 2012 Sep 10;162(2):373-81. doi: 10.1016/j.jconrel.2012.06.033. Epub 2012 Jul 4.

PMID:
22771533
43.

The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.

Dubé L, Caillon J, Jacqueline C, Bugnon D, Potel G, Asseray N.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2545-7. Epub 2012 Mar 8.

PMID:
22395262
44.

Evaluation of doripenem in an experimental model of resistant Pseudomonas aeruginosa pneumonia.

Bretonnière C, Jacqueline C, Caillon J, Guitton C, Desessard C, Le Mabecque V, Miégeville AF, Villers D, Potel G, Boutoille D.

J Antimicrob Chemother. 2012 Mar;67(3):780-1. doi: 10.1093/jac/dkr528. Epub 2011 Dec 18. No abstract available.

PMID:
22184470
45.

Antenatal phosphodiesterase 4 inhibition restores postnatal growth and pulmonary development in a model of chorioamnionitis in rabbits.

Homer L, Launay E, Joram N, Jacqueline C, Jarreau PH, Caillon J, Moyon T, Branger B, Potel G, Roze JC, Méhats C, Gras-Leguen C.

J Pharmacol Exp Ther. 2012 Mar;340(3):620-8. doi: 10.1124/jpet.111.179085. Epub 2011 Dec 7.

PMID:
22160266
46.

Diffusion of ofloxacin in the endocarditis vegetation assessed with synchrotron radiation UV fluorescence microspectroscopy.

Batard E, Jamme F, Villette S, Jacqueline C, de la Cochetière MF, Caillon J, Réfrégiers M.

PLoS One. 2011 Apr 29;6(4):e19440. doi: 10.1371/journal.pone.0019440.

47.

Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Jacqueline C, Amador G, Batard E, Le Mabecque V, Miègeville AF, Biek D, Caillon J, Potel G.

J Antimicrob Chemother. 2011 Apr;66(4):863-6. doi: 10.1093/jac/dkr019. Epub 2011 Jan 31.

PMID:
21393213
48.

A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit.

Gaudin A, Amador Del Valle G, Hamel A, Le Mabecque V, Miegeville AF, Potel G, Caillon J, Jacqueline C.

Lett Appl Microbiol. 2011 Mar;52(3):253-7. doi: 10.1111/j.1472-765X.2010.02992.x. Epub 2011 Jan 11.

49.

CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia.

Roquilly A, Gautreau L, Segain JP, de Coppet P, Sebille V, Jacqueline C, Caillon J, Potel G, Lejus C, Josien R, Asehnoune K.

PLoS One. 2010 Oct 7;5(10):e13228. doi: 10.1371/journal.pone.0013228.

50.

Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem.

Bretonnière C, Jacqueline C, Caillon J, Guitton C, Le Mabecque V, Miégeville AF, Villers D, Potel G, Boutoille D.

J Antimicrob Chemother. 2010 Nov;65(11):2423-7. doi: 10.1093/jac/dkq334. Epub 2010 Sep 21.

PMID:
20858688

Supplemental Content

Loading ...
Support Center